Eprodisate for the Treatment of Renal Disease in AA Amyloidosis
Eprodisate for the Treatment of Renal Disease in AA Amyloidosis
About this item
Full title
Author / Creator
Dember, Laura M , Hawkins, Philip N , Hazenberg, Bouke P.C , Gorevic, Peter D , Merlini, Giampaolo , Butrimiene, Irena , Livneh, Avi , Lesnyak, Olga , Puéchal, Xavier , Lachmann, Helen J , Obici, Laura , Balshaw, Robert , Garceau, Denis , Hauck, Wendy , Skinner, Martha and Eprodisate for AA Amyloidosis Trial Group
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Amyloid A (AA) amyloidosis, a complication of chronic inflammatory conditions, develops when proteolytic fragments of serum amyloid A protein are deposited in tissues as amyloid fibrils. This placebo-controlled trial investigated the effect of eprodisate, a small molecule that inhibits amyloid fibril polymerization and tissue deposition in patients...
Alternative Titles
Full title
Eprodisate for the Treatment of Renal Disease in AA Amyloidosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223919439
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223919439
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa065644
